Megna Michael R
Insider CIK 1464583 · KNSA Chief Accounting Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2026-09-03 | 2026-09-03 | 4,600 | $80.30 | $369.4K | 29,062 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2026-09-03 | 2026-09-03 | 4,600 | $80.30 | $369.4K | 29,062 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-09-01 | 2026-09-03 | 2,362 | — | $0 | 4,725 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2026-09-01 | 2026-09-03 | 3,650 | — | $0 | 3,650 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-09-01 | 2026-09-03 | 3,932 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-09-01 | 2026-09-03 | 2,558 | — | $0 | 2,557 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-09-01 | 2026-09-03 | 2,644 | — | $0 | 7,931 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2026-09-01 | 2026-09-03 | 14,600 | — | $0 | 14,600 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-09-01 | 2026-09-03 | 2,644 | — | $0 | 39,193 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-09-01 | 2026-09-03 | 3,932 | — | $0 | 31,629 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-09-01 | 2026-09-03 | 2,558 | — | $0 | 34,187 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-09-01 | 2026-09-03 | 2,362 | — | $0 | 36,549 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | F Tax w/h | 2026-09-01 | 2026-09-03 | 5,531 | $79.28 | $438.5K | 33,662 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-09-01 | 2026-09-03 | 3,932 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-09-01 | 2026-09-03 | 2,558 | — | $0 | 2,557 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-09-01 | 2026-09-03 | 2,362 | — | $0 | 4,725 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-09-01 | 2026-09-03 | 2,644 | — | $0 | 7,931 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2026-09-01 | 2026-09-03 | 14,600 | — | $0 | 14,600 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2026-09-01 | 2026-09-03 | 3,650 | — | $0 | 3,650 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | F Tax w/h | 2026-09-01 | 2026-09-03 | 5,531 | $79.28 | $438.5K | 33,662 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-09-01 | 2026-09-03 | 2,644 | — | — | 39,193 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-09-01 | 2026-09-03 | 2,362 | — | — | 36,549 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-09-01 | 2026-09-03 | 2,558 | — | — | 34,187 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-09-01 | 2026-09-03 | 3,932 | — | — | 31,629 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award | 2026-07-15 | 2026-09-03 | 279 | $33.50 | $9.3K | 27,697 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award | 2026-07-15 | 2026-09-03 | 279 | $33.50 | $9.3K | 27,697 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2026-04-09 | 2026-04-13 | 6,625 | $46.69 | $309.3K | 27,418 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-04-07 | 2026-04-08 | 3,932 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | F Tax w/h | 2026-04-07 | 2026-04-08 | 1,666 | $48.94 | $81.5K | 34,043 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-04-07 | 2026-04-08 | 3,932 | $1.00 | $3.9K | 35,709 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2026-04-01 | 2026-04-03 | 7,300 | — | $0 | 7,300 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2026-04-01 | 2026-04-03 | 3,650 | — | $0 | 3,650 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-04-01 | 2026-04-03 | 2,558 | — | $0 | 2,557 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-04-01 | 2026-04-03 | 2,362 | — | $0 | 4,725 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2026-04-01 | 2026-04-03 | 14,600 | — | $0 | 14,600 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-04-01 | 2026-04-03 | 2,644 | — | $0 | 7,931 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | F Tax w/h | 2026-04-01 | 2026-04-03 | 3,205 | $48.13 | $154.3K | 31,777 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-04-01 | 2026-04-03 | 7,564 | — | $0 | 34,982 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award | 2026-01-15 | 2026-04-03 | 372 | $24.16 | $9.0K | 27,418 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-10-20 | 2025-10-22 | 12,787 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-10-20 | 2025-10-22 | 9,831 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-10-20 | 2025-10-22 | 9,831 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-10-20 | 2025-10-22 | 6,195 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-10-20 | 2025-10-22 | 791 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-10-20 | 2025-10-22 | 13,235 | $39.31 | $520.3K | 27,046 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-10-20 | 2025-10-22 | 37,255 | $38.72 | $1.44M | 40,281 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-10-20 | 2025-10-22 | 12,787 | $10.76 | $137.6K | 77,536 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-10-20 | 2025-10-22 | 9,831 | $11.97 | $117.7K | 64,749 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-10-20 | 2025-10-22 | 9,831 | $11.10 | $109.1K | 54,918 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-10-20 | 2025-10-22 | 6,195 | $12.97 | $80.3K | 45,087 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-10-20 | 2025-10-22 | 791 | $15.50 | $12.3K | 38,892 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-10-04 | 2025-10-08 | 175 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-10-04 | 2025-10-08 | 175 | — | $0 | 38,186 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | F Tax w/h | 2025-10-04 | 2025-10-08 | 85 | $38.49 | $3.3K | 38,101 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-09-03 | 2025-09-03 | 11,000 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-09-03 | 2025-09-03 | 11,000 | $34.84 | $383.2K | 38,011 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-09-03 | 2025-09-03 | 11,000 | $17.92 | $197.1K | 49,011 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-09-02 | 2025-09-03 | 774 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | F Tax w/h | 2025-09-02 | 2025-09-03 | 375 | $34.28 | $12.9K | 38,011 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-09-02 | 2025-09-03 | 774 | — | $0 | 38,386 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2025-09-01 | 2025-09-03 | 10,575 | — | $0 | 10,575 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2025-09-01 | 2025-09-03 | 21,150 | — | $0 | 21,150 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-09-01 | 2025-09-03 | 2,363 | — | $0 | 7,087 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-09-01 | 2025-09-03 | 3,933 | — | $0 | 3,932 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-09-01 | 2025-09-03 | 2,557 | — | $0 | 5,115 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | F Tax w/h | 2025-09-01 | 2025-09-03 | 4,282 | $33.49 | $143.4K | 37,612 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-09-01 | 2025-09-03 | 2,363 | — | $0 | 35,404 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-09-01 | 2025-09-03 | 2,557 | — | $0 | 37,961 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-09-01 | 2025-09-03 | 3,933 | — | $0 | 41,894 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-08-04 | 2025-08-06 | 17,000 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-08-04 | 2025-08-06 | 17,000 | $32.35 | $550.0K | 33,041 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-08-04 | 2025-08-06 | 17,000 | $15.52 | $263.8K | 50,041 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award | 2025-07-15 | 2025-08-06 | 495 | $15.63 | $7.7K | 33,041 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-06-03 | 2025-06-05 | 15,211 | — | $0 | 791 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-06-03 | 2025-06-05 | 15,211 | $28.75 | $437.3K | 32,546 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-06-03 | 2025-06-05 | 15,211 | $15.50 | $235.8K | 47,757 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-05-07 | 2025-05-09 | 2,998 | — | $0 | 16,002 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-05-07 | 2025-05-09 | 14,420 | — | $0 | 17,040 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-05-07 | 2025-05-09 | 229 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-05-07 | 2025-05-09 | 14,420 | $11.97 | $172.6K | 50,193 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-05-07 | 2025-05-09 | 17,647 | $26.69 | $471.0K | 32,546 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-05-07 | 2025-05-09 | 2,998 | $15.50 | $46.5K | 35,773 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-05-07 | 2025-05-09 | 229 | $8.83 | $2.0K | 32,775 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2025-05-01 | 2025-05-05 | 3,433 | — | $0 | 3,433 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2025-05-01 | 2025-05-05 | 3,270 | — | $0 | 3,270 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2025-05-01 | 2025-05-05 | 5,285 | — | $0 | 5,285 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2025-05-01 | 2025-05-05 | 5,456 | — | $0 | 5,456 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-04-07 | 2025-04-09 | 3,933 | — | $0 | 3,932 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-04-07 | 2025-04-09 | 3,933 | — | $0 | 34,212 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | F Tax w/h | 2025-04-07 | 2025-04-09 | 1,666 | $20.28 | $33.8K | 32,546 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-04-01 | 2025-04-03 | 2,557 | — | $0 | 5,115 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2025-04-01 | 2025-04-03 | 10,575 | — | $0 | 10,575 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2025-04-01 | 2025-04-03 | 21,150 | — | $0 | 21,150 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-04-01 | 2025-04-03 | 2,363 | — | $0 | 7,087 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-04-01 | 2025-04-03 | 2,363 | — | $0 | 32,363 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-04-01 | 2025-04-03 | 2,557 | — | $0 | 30,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | F Tax w/h | 2025-04-01 | 2025-04-03 | 1,083 | $21.77 | $23.6K | 31,280 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | F Tax w/h | 2025-04-01 | 2025-04-03 | 1,001 | $21.77 | $21.8K | 30,279 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-03-16 | 2025-03-19 | 774 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | F Tax w/h | 2025-03-16 | 2025-03-19 | 328 | $22.61 | $7.4K | 27,443 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-03-16 | 2025-03-19 | 774 | — | $0 | 27,771 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-03-12 | 2025-03-14 | 9,051 | — | $0 | 13,763 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-03-12 | 2025-03-14 | 9,051 | $22.45 | $203.2K | 26,528 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-03-12 | 2025-03-14 | 9,051 | $11.10 | $100.5K | 35,579 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award | 2025-01-15 | 2025-03-19 | 469 | $16.00 | $7.5K | 26,997 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2024-11-29 | 2024-12-02 | 9 | — | $0 | 22,814 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2024-11-29 | 2024-12-02 | 9 | $11.10 | $100 | 26,537 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2024-11-29 | 2024-12-02 | 9 | $22.45 | $202 | 26,528 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2024-11-27 | 2024-12-02 | 8,637 | — | $0 | 22,823 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2024-11-27 | 2024-12-02 | 8,637 | $22.45 | $193.9K | 26,528 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2024-11-27 | 2024-12-02 | 8,637 | $11.10 | $95.9K | 35,165 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2024-10-04 | 2024-10-08 | 175 | — | $0 | 175 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | F Tax w/h | 2024-10-04 | 2024-10-08 | 82 | $24.48 | $2.0K | 26,528 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2024-10-04 | 2024-10-08 | 175 | — | $0 | 26,610 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2024-09-02 | 2024-09-04 | 775 | — | $0 | 774 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | F Tax w/h | 2024-09-02 | 2024-09-04 | 329 | $26.74 | $8.8K | 26,435 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2024-09-02 | 2024-09-04 | 775 | — | $0 | 26,764 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2024-09-01 | 2024-09-04 | 3,932 | — | $0 | 7,865 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2024-09-01 | 2024-09-04 | 2,558 | — | $0 | 7,672 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2024-09-01 | 2024-09-04 | 18,900 | — | $0 | 18,900 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2024-09-01 | 2024-09-04 | 9,450 | — | $0 | 9,450 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | F Tax w/h | 2024-09-01 | 2024-09-04 | 2,755 | $26.74 | $73.7K | 25,989 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2024-09-01 | 2024-09-04 | 6,490 | — | $0 | 28,744 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award | 2024-07-15 | 2024-09-04 | 480 | $15.65 | $7.5K | 22,254 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2024-04-08 | 2024-04-08 | 3,932 | — | $0 | 13,190 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | F Tax w/h | 2024-04-08 | 2024-04-08 | 1,666 | $17.90 | $29.8K | 21,328 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2024-04-08 | 2024-04-08 | 3,932 | — | $0 | 22,994 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2024-04-04 | 2024-04-08 | 18,900 | — | $0 | 18,900 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2024-04-04 | 2024-04-08 | 9,450 | — | $0 | 17,122 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2024-04-01 | 2024-04-03 | 2,558 | — | $0 | 7,672 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | F Tax w/h | 2024-04-01 | 2024-04-03 | 1,084 | $19.70 | $21.4K | 19,062 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2024-04-01 | 2024-04-03 | 2,558 | — | $0 | 20,146 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2024-03-01 | 2024-03-01 | 4,014 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2024-03-01 | 2024-03-01 | 5,645 | — | $0 | 229 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2024-03-01 | 2024-03-01 | 4,014 | $13.88 | $55.7K | 27,247 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2024-03-01 | 2024-03-01 | 5,645 | $8.83 | $49.8K | 23,233 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | S Sale | 2024-03-01 | 2024-03-01 | 9,659 | $21.45 | $207.2K | 17,588 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2024-02-28 | 2024-03-01 | 5,126 | — | $0 | 5,874 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | S Sale | 2024-02-28 | 2024-03-01 | 5,126 | $21.79 | $111.7K | 17,588 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2024-02-28 | 2024-03-01 | 5,126 | $8.83 | $45.3K | 22,714 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award | 2024-01-15 | 2024-03-01 | 583 | $12.35 | $7.2K | 17,588 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2024-01-02 | 2024-01-04 | 16,670 | — | $0 | 4,014 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | S Sale | 2024-01-02 | 2024-01-04 | 16,670 | $19.17 | $319.6K | 17,005 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2024-01-02 | 2024-01-04 | 16,670 | $13.88 | $231.4K | 33,675 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2023-12-19 | 2023-12-21 | 9,316 | — | $0 | 20,684 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2023-12-19 | 2023-12-21 | 9,316 | $13.88 | $129.3K | 26,321 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | S Sale | 2023-12-19 | 2023-12-21 | 9,316 | $19.13 | $178.2K | 17,005 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2023-10-04 | 2023-10-06 | 175 | — | $0 | 350 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | F Tax w/h | 2023-10-04 | 2023-10-06 | 52 | $16.01 | $833 | 17,005 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2023-10-04 | 2023-10-06 | 175 | — | $0 | 17,057 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2023-09-02 | 2023-09-06 | 774 | — | $0 | 1,549 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2023-09-02 | 2023-09-06 | 774 | — | $0 | 17,110 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | F Tax w/h | 2023-09-02 | 2023-09-06 | 228 | $17.76 | $4.0K | 16,882 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2023-09-01 | 2023-09-06 | 20,459 | — | $0 | 20,459 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2023-09-01 | 2023-09-06 | 3,933 | — | $0 | 11,797 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2023-09-01 | 2023-09-06 | 10,230 | — | $0 | 10,230 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | F Tax w/h | 2023-09-01 | 2023-09-06 | 1,155 | $17.76 | $20.5K | 16,336 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2023-09-01 | 2023-09-06 | 3,933 | — | $0 | 17,491 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award | 2023-07-15 | 2023-09-06 | 581 | $12.35 | $7.2K | 13,558 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2023-04-10 | 2023-04-11 | 3,933 | — | $0 | 11,797 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2023-04-10 | 2023-04-11 | 3,933 | — | $0 | 14,132 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | F Tax w/h | 2023-04-10 | 2023-04-11 | 1,155 | $10.71 | $12.4K | 12,977 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2023-04-01 | 2023-04-03 | 10,230 | — | $0 | 10,230 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2023-04-01 | 2023-04-03 | 20,459 | — | $0 | 20,459 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2023-03-20 | 2023-03-20 | 2,163 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | F Tax w/h | 2023-03-20 | 2023-03-20 | 635 | $11.12 | $7.1K | 10,199 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2023-03-20 | 2023-03-20 | 2,163 | — | $0 | 10,834 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2023-03-16 | 2023-03-20 | 774 | — | $0 | 1,549 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | F Tax w/h | 2023-03-16 | 2023-03-20 | 221 | $11.46 | $2.5K | 8,671 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2023-03-16 | 2023-03-20 | 774 | — | $0 | 8,892 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award | 2023-01-15 | 2023-03-20 | 704 | $9.56 | $6.7K | 8,118 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2022-10-04 | 2022-10-06 | 175 | — | $0 | 525 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | F Tax w/h | 2022-10-04 | 2022-10-06 | 52 | $14.23 | $740 | 7,414 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2022-10-04 | 2022-10-06 | 175 | — | $0 | 7,466 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2022-09-02 | 2022-09-06 | 775 | — | $0 | 2,323 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | F Tax w/h | 2022-09-02 | 2022-09-06 | 228 | $11.44 | $2.6K | 7,291 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2022-09-02 | 2022-09-06 | 775 | — | $0 | 7,519 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2022-09-01 | 2022-09-06 | 15,730 | — | $0 | 15,730 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2022-09-01 | 2022-09-06 | 31,460 | — | $0 | 31,460 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award | 2022-07-15 | 2022-09-06 | 703 | $9.56 | $6.7K | 6,744 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2022-04-07 | 2022-04-11 | 15,730 | — | $0 | 15,730 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2022-04-07 | 2022-04-11 | 31,460 | — | $0 | 31,460 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2022-03-21 | 2022-03-23 | 3,231 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2022-03-21 | 2022-03-23 | 3,231 | — | $0 | 7,161 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | F Tax w/h | 2022-03-21 | 2022-03-23 | 1,120 | $10.98 | $12.3K | 6,041 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2022-03-16 | 2022-03-18 | 775 | — | $0 | 2,323 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | F Tax w/h | 2022-03-16 | 2022-03-18 | 269 | $10.13 | $2.7K | 3,930 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2022-03-16 | 2022-03-18 | 775 | — | $0 | 4,199 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award | 2022-01-15 | 2022-03-18 | 653 | $9.63 | $6.3K | 3,424 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2021-10-04 | 2021-10-06 | 700 | — | $0 | 700 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2021-09-02 | 2021-09-07 | 6,195 | — | $0 | 6,195 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2021-09-02 | 2021-09-07 | 3,098 | — | $0 | 3,098 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award | 2021-07-15 | 2022-03-18 | 588 | $11.49 | $6.8K | 2,771 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2021-03-20 | 2021-03-23 | 3,231 | — | $0 | 3,231 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2021-03-20 | 2021-03-23 | 2,163 | — | $0 | 2,163 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2021-03-16 | 2021-03-18 | 3,098 | — | $0 | 3,098 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2021-03-16 | 2021-03-18 | 6,195 | — | $0 | 6,195 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award | 2020-12-31 | 2022-03-18 | 405 | $15.02 | $6.1K | 2,183 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2020-09-10 | 2020-09-14 | 19,000 | — | $0 | 19,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award | 2020-06-30 | 2022-03-18 | 641 | $9.51 | $6.1K | 1,778 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2020-03-13 | 2020-03-17 | 17,000 | — | $0 | 17,000 | SEC↗ |